Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: A meta-analysis

Table 2 Origin of the included studies and Jadad score

No.	Authors	Titles	Jadad score
1	Schuhmacher et al[15]	Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organization for Research and Treatment of Cancer randomized trial 40954	4
2	Boige et al[11]	Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial	4
3	Cunningham et al[12]	Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer	7
4	Hartgrink et al[13]	Neoadjuvant chemotherapy for operable gastric cancer: long-term results of the Dutch randomized FAMTX trial	5
5	Zhang et al[17]	Clinical significance of preoperative regional intra-arterial infusion chemotherapy for advanced gastric cancer	2
6	Kobayashi et al[14]	Long-term outcome of preoperative chemotherapy with 5'-deoxy-5-fluorouridine (5'-DFUR) for gastric cancer	3
7	Wang et al[16]	A favorable impact of preoperative FPLC chemotherapy on patients with gastric cardia cancer	3

FAMTX: 5-FU/adriamycin/methotrexate; FPLC: Fluorouracili polyphase liposome composita pro orale; FNCLCC: Fe´de´ ration Nationale des Centres de Lutte Contrele Cancer; FFCD: Fe´de´ ration Francophonede Cance´ rologie Digestive Collaborative Groups.